Rapidly progressive glomerulonephritis x-ray findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 1: Line 1:
__NOTOC__  
__NOTOC__  
{{Rapidly progressive glomerulonephritis}}  
{{Rapidly progressive glomerulonephritis}}  
{{CMG}}; {{AE}} {{AEL}}  
{{CMG}}; {{AE}} {{AEL}}  {{ N.F }}


==Overview==
==Overview==

Latest revision as of 19:30, 31 July 2018

Rapidly progressive glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rapidly progressive glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray Findings

CT-scan Findings

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rapidly progressive glomerulonephritis x-ray findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rapidly progressive glomerulonephritis x-ray findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rapidly progressive glomerulonephritis x-ray findings

CDC on Rapidly progressive glomerulonephritis x-ray findings

Rapidly progressive glomerulonephritis x-ray findings in the news

Blogs on Rapidly progressive glomerulonephritis x-ray findings

Directions to Hospitals Treating Rapidly progressive glomerulonephritis

Risk calculators and risk factors for Rapidly progressive glomerulonephritis x-ray findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2] Nazia Fuad M.D.

Overview

There are no x-ray findings associated with rapidly progressive glomerulonephritis unless it is associated with anti-GBM antibody disease (Goodpasture syndrome). On chest X-ray, Goodpasture syndrome is characterized by parenchymal consolidations that are most often present in both lungs, perihilar, and bibasilar. When pulmonary hemorrhage is recurrent an interstitial pattern is observed.

X Ray

  • There are no x-ray findings associated with rapidly progressive glomerulonephritis, except in anti-GBM antibody (Goodpasture syndrome).
  • In Goodpasture syndrome, chest x-ray findings include the following:
Note: Diffuse alveolar hemorrhage throughout both lung fields in Goodpasture syndrome ([Case courtesy of Dr Sajoscha Sorrentino, <a href="https://radiopaedia.org/">Radiopaedia.org</a>])

References

  1. Greco A, Rizzo MI, De Virgilio A, Gallo A, Fusconi M, Pagliuca G; et al. (2015). "Goodpasture's syndrome: a clinical update". Autoimmun Rev. 14 (3): 246–53. doi:10.1016/j.autrev.2014.11.006. PMID 25462583.
  2. Case courtesy of Dr Sajoscha Sorrentino. https://radiopaedia.org/cases/14859 Accessed on November 4, 2016